Pfizer and Mylan have agreed on terms by which Mylan may launch its generic version of Pfizer's Detrol LA (tolterodine tartrate) extended-release capsules, pending final approval by FDA. Pfizer and ...

Global pharmaceutical company Pfizer has announced that it has settled its litigation against Mylan Pharmaceuticals relating to Pfizer’s patents covering Detrol LA (tolterodine tartrate) ...

Mylan announced it has received final approval from the FDA for its Abbreviated New Drug Application (ANDA) of Tolterodine Tartrate Extended-Release (ER) Capsules, the generic version of Pfizer’s ...

Teva Pharmaceuticals announced the launch of Tolterodine Tartrate Tablets, the generic version of Pfizer‘s Detrol tablets. Detrol is a muscarinic antagonist indicated for treatment of overactive ...

Thermo Fisher Scientific has announced two new ion chromatography (IC) methods designed to reduce time and labor and increase accuracy when determining tartrate in drug products containing tolterodine ...